CELL THERAPY, STEM CELLS AND TISSUES
Instituto de Investigación Biomédica de Salamanca
Salamanca, EspañaPublications in collaboration with researchers from Instituto de Investigación Biomédica de Salamanca (1)
2022
-
Discoidin Domain Receptor 2 Expression as Worse Prognostic Marker in Invasive Breast Cancer
The breast journal, Vol. 2022, pp. 5169405